Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for prevention of postoperative delirium in elderly orthopedic surgery patients
IRCT20170515033986N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ondansetron in delirium (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Delirium. Started Nov 2020; status: completed.
02
Drugs
ondansetron
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20170515033986N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170515033986N1.